- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Dec 31, 2024 | 26.44M sh |
| Shares Diluted restated | Q2 2025 · Dec 31, 2023 | 26.44M sh |
| Operating Cash Flow | Q2 2025 · Dec 31, 2024 | −$2.04M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2024 | −9.15M |
| Operating Cash Flow restated | Q2 2025 · Dec 31, 2023 | $16.12M |
| Operating Cash Flow restated | Q2 2025 · Dec 31, 2023 | 74.06M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $491.74K |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | 2.2M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $2.23M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | 9.99M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2023 | $6.55M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2023 | 30.08M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2023 | $6.85M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2023 | 31.45M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $52.58M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | 235.57M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $55.92M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | 264.08M |
| Stockholders Equity restated | Q2 2025 · Dec 31, 2023 | 302.73M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | 318.84M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $13.94M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | 62.45M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $335.58K |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | 1.58M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $15.34M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | 68.73M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $1.87M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | 8.83M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $28.16M |
| Current Assets | Q2 2025 · Dec 31, 2024 | 126.17M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $14.98M |
| Current Assets | Q2 2025 · Jun 30, 2024 | 70.72M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $67.92M |
| Total Assets | Q2 2025 · Dec 31, 2024 | 304.3M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $57.8M |
| Total Assets | Q2 2025 · Jun 30, 2024 | 272.91M |
| Eps Diluted | Q2 2025 · Dec 31, 2024 | −$0.23 |
| Eps Diluted | Q2 2025 · Dec 31, 2024 | −1.04 |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −$0.16 |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −0.73 |
| Eps Basic | Q2 2025 · Dec 31, 2024 | −$0.23 |
| Eps Basic | Q2 2025 · Dec 31, 2024 | −1.04 |
| Eps Basic restated | Q2 2025 · Dec 31, 2023 | −$0.16 |
| Eps Basic restated | Q2 2025 · Dec 31, 2023 | −0.73 |
| Net Income | Q2 2025 · Dec 31, 2024 | −$6.15M |
| Net Income | Q2 2025 · Dec 31, 2024 | −27.54M |
| Net Income | Q2 2025 · Jun 30, 2024 | −18.88M |
| Net Income restated | Q2 2025 · Dec 31, 2023 | −$4.11M |
| Net Income restated | Q2 2025 · Dec 31, 2023 | −18.88M |
| Gross Profit | Q2 2025 · Dec 31, 2024 | $613.84K |
| Gross Profit | Q2 2025 · Dec 31, 2024 | 2.75M |
| Gross Profit restated | Q2 2025 · Dec 31, 2023 | $606.23K |
| Gross Profit restated | Q2 2025 · Dec 31, 2023 | 2.79M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2024 | $17.83M |
| Cost Of Revenue | Q2 2025 · Dec 31, 2024 | 79.9M |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2023 | $6.28M |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2023 | 28.84M |
| Revenue | Q2 2025 · Dec 31, 2024 | $18.45M |
| Revenue | Q2 2025 · Dec 31, 2024 | 82.65M |
| Revenue | Q2 2025 · Jun 30, 2024 | 31.62M |
| Revenue | Q2 2025 · Dec 31, 2023 | $6.88M |
| Revenue | Q2 2025 · Dec 31, 2023 | 31.62M |